Hepcidin has demonstrated its role as a biomarker for iron homeostasis [19], but its utility as a predictor of clinical outcome should be explored in more detail, in particular how much incremental prognostic value is carried in addition to established risk factors, such as age, GFR, and anemia. This evidence concerns the gene HAMP and anemia.